April 9, 2024 New treatment improves quality of life for children with DMD Elevidys is a new gene therapy treatment for Duchenne Muscular Dystrophy (DMD). Learn how Elevidys increases dystrophin production in young children with DMD and its potential to profoundly improve quality of life.
February 15, 2024 New gene therapies change outcomes for rare blood disorders Children’s Health is among the first centers in the country to offer gene therapies for sickle cell disease and other rare blood disorders. In this Q&A, we discuss the data, benefits and care considerations related to these therapies.
February 8, 2024 Case Study: Uncovering urinary and clinical distinctions of HADDS in Children Our urology team is building unique expertise on the urinary complications of HADDS. This case study reveals unique details about the condition’s impact on the bladder and how to approach treatment.
February 4, 2024 Q&A: How integrative medicine for IBD improves quality of life for children Recent studies have reported clinical benefits of using integrative medicine in children with IBD. This holistic methodology focuses on the brain-gut connection to improve symptoms and quality of life.
February 2, 2024 Supporting neurodevelopment of pediatric heart patients: 4 new initiatives New cardiac neurodevelopmental initiatives at Children’s Health identify neurodevelopmental concerns in children with heart conditions early. See how our team ensures pediatric heart patients enjoy success in school and life.
January 30, 2024 Using intra-arterial chemotherapy to treat retinoblastoma in children Discover how intra-arterial chemotherapy treats retinoblastoma and improves the chances of saving children’s eyes. Our experts discuss this innovative treatment.